Oncology & Cancer

Pill halves risk of death in type of lung cancer

A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.

Oncology & Cancer

Oncology therapy at the end-of-life: Have we missed the mark?

Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and hospice enrollment, escalates costs, and may adversely affect the quality of care patients receive. Accordingly, over ...

page 1 from 34